Mercer Global Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,668
Closed -$220K 2009
2022
Q3
$220K Sell
4,668
-66
-1% -$4.26K ﹤0.01% 1581
2022
Q2
$339K Buy
4,734
+90
+2% +$6.58K ﹤0.01% 1362
2022
Q1
$376K Buy
+4,644
New +$393K ﹤0.01% 1384

Other funds holding SYNH

Mercer Global Advisors's SYNH Position: Q4 2022 in Review

Mercer Global Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 4,668 shares — an estimated $220K sold.

Mercer Global Advisors first reported a position in SYNH in Q1 2022 and held it in 3 quarters. The position peaked at $376K in Q1 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Mercer Global Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Mercer Global Advisors sold 4,668 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $220K.
  • Mercer Global Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2022 and held it in 3 quarters.
  • Mercer Global Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $376K in Q1 2022.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Mercer Global Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.